KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.2 | - |
NeuAcalpha(2,3)Galbeta(1,4)GlcNAc | - |
Homo sapiens | |
0.7 | - |
Fucalpha(1,2)Galbeta(1,4)GlcNAc | - |
Homo sapiens | |
1.4 | - |
Galbeta(1,4)GlcNAc | - |
Homo sapiens | |
3.9 | - |
NeuAcalpha(2,3)Galbeta(1,4)Glc | - |
Homo sapiens | |
6.7 | - |
Fucalpha(1,2)Galbeta(1,4)Glc | - |
Homo sapiens | |
25 | - |
Galbeta(1,4)Glc | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood plasma | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
GDP-beta-L-fucose + NeuAcalpha(2,3)Galbeta(1,4)Glc | - |
Homo sapiens | ? | - |
? | |
GDP-L-fucose + Fucalpha(1,2)Galbeta(1,4)Glc | i.e. 2'-fucosyllactose, 17% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + Fucalpha(1,2)Galbeta(1,4)(Fucalpha(1,3))Glc | - |
? | |
GDP-L-fucose + Fucalpha(1,2)Galbeta(1,4)GlcNAc | 162% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + Fucalpha(1,2)Galbeta(1,4)(Fucalpha(1,3))GlcNAc | - |
? | |
GDP-L-fucose + Galbeta(1,4)-Glc | 3% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + Galbeta(1,4)(Fucalpha(1,3))Glc | - |
? | |
GDP-L-fucose + Galbeta(1,4)GlcNAc | i.e. N-acetyllactosamine | Homo sapiens | GDP + Galbeta(1,4)(Fucalpha(1,3))GlcNAc | - |
? | |
GDP-L-fucose + NeuAcalpha(2,3)Galbeta(1,4)GlcNAc | 147% of the activity with Galbeta(1,4)GlcNAc | Homo sapiens | GDP + NeuAcalpha(2,3)Galbeta(1,4)(Fucalpha(1,3))GlcNAc | - |
? | |
additional information | no activity with Galbeta(1,3)GlcNAc, NeuAcalpha2,6Galbeta(1,4)GlcNAc, NeuAcalpha2,8NeuAc and NeuAcalpha2,6Galbeta(1,4)Glc | Homo sapiens | ? | - |
? |